Cann American Stock Price, News & Analysis
Company Description
Cann American (OTC Link: CNNA) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $994.3K.
CNNA stock has declined 64.3% over the past year. Shares last traded at $0.0015.
On a trailing twelve-month basis, Cann American reported net income of -$1.7M and diluted earnings per share of $1000000.00.
This page provides a comprehensive overview of CNNA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cann American (CNNA) stock last traded at $0.0015. Over the past 12 months, the stock has lost 64.3%. At a market capitalization of $994.3K, CNNA is classified as a micro-cap stock with approximately 261.7M shares outstanding.
Latest News
Cann American has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition. View all CNNA news →
SEC Filings
Financial Highlights
operating income reached -$1.7M, and net income was -$1.7M. Diluted earnings per share stood at $1000000.00. The company generated -$65K in operating cash flow. With a current ratio of 0.00, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Cann American (CNNA) currently stands at 210.0 thousand shares.
Days to Cover History
Days to cover for Cann American (CNNA) currently stands at 1.3 days, down 80.1% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 52.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.3 to 1000.0 days.
CNNA Company Profile & Sector Positioning
Cann American (CNNA) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CNNA often look at related companies in the same sector, including Pharmadrug Inc (LMLLF), Petros Pharmaceuticals Inc (PTPI), Premier Biomedical Inc (BIEI), Kaya Hldgs Inc (KAYS), and Resonate Blends Inc (KOAN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNNA's relative position within its industry.